Revenue ($USD) : $820,000,000 R&D spend : $30,600,000.00 Employees : 4,044 Fiscal year end : 12/31/22 CEO : Joseph Woody
Avanos Medical develops medtech focused on two areas: non-opioid pain management and chronic care, the latter of which includes digestive health, respiratory health, NICU and pharmacy products. In June, it announced plans to acquire Toronto-based Diros Technology and its radiofrequency products to treat chronic pain conditions. The same month, it agreed to sell its respiratory health business to SunMed Group Holdings. Both deals were expected to close by 2024. –CN and DK
